EX-99.3 4 financialstatementsusgaapq.htm EX-99.3 Document
Exhibit 99.3

ASML - Summary US GAAP Consolidated Statements of Operations
Three months ended,
Mar 29,Apr 4,
(unaudited, in millions €, except per share data)20202021
Net system sales1,584.0 3,128.8 
Net service and field option sales856.6 1,235.1 
Total net sales2,440.6 4,363.9 
Total cost of sales(1,339.2)(2,011.5)
Gross profit1,101.4 2,352.4 
Research and development costs(544.0)(623.4)
Selling, general and administrative costs(130.7)(168.4)
Income from operations426.7 1,560.6 
Interest and other, net(11.4)(12.1)
Income before income taxes415.3 1,548.5 
Income tax expense(48.5)(230.3)
Income after income taxes366.8 1,318.2 
Profit related to equity method investments23.8 13.2 
Net income390.6 1,331.4 
Basic net income per ordinary share0.93 3.21 
Diluted net income per ordinary share0.93 3.20 
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic419.0 415.3 
Diluted419.7 415.8 

ASML - Ratios and Other Data
Three months ended,
Mar 29,Apr 4,
(unaudited, in millions €, except otherwise indicated)20202021
Gross profit as a percentage of net sales45.1 %53.9 %
Income from operations as a percentage of net sales 17.5 %35.8 %
Net income as a percentage of net sales16.0 %30.5 %
Income taxes as a percentage of income before income taxes11.7 %14.9 %
Shareholders’ equity as a percentage of total assets 53.8 %50.1 %
Sales of lithography systems (in units) 1
57 76 
Value of booked systems (EUR millions) 2
3,085 4,740 
Net bookings lithography systems (in units) 1, 2
73 120 
Number of payroll employees in FTEs23,860 27,248 
Number of temporary employees in FTEs1,467 1,561 











1     Lithography systems do not include metrology and inspection systems.
2 Our systems net bookings include all system sales orders for which written authorizations have been accepted (for EUV excluding the High-NA systems).


ASML - Summary US GAAP Consolidated Balance Sheets
Dec 31,Apr 4,
 (unaudited, in millions €)20202021
ASSETS
Cash and cash equivalents6,049.4 3,243.8 
Short-term investments1,302.2 1,411.6 
Accounts receivable, net1,310.3 2,239.2 
Finance receivables, net1,710.5 2,218.6 
Current tax assets67.3 809.7 
Contract assets119.2 107.4 
Inventories, net4,569.4 4,748.1 
Other assets801.7 915.7 
Held for sale assets— 165.5 
Total current assets15,930.0 15,859.6 
Finance receivables, net400.5 66.6 
Deferred tax assets671.5 700.8 
Other assets951.4 1,313.4 
Equity method investments820.7 842.5 
Goodwill4,629.1 4,555.5 
Other intangible assets, net1,049.0 1,014.2 
Property, plant and equipment, net 2,470.3 2,521.6 
Right-of-use assets - Operating180.1 179.7 
Right-of-use assets - Finance164.8 164.8 
Total non-current assets11,337.4 11,359.1 
Total assets27,267.4 27,218.7 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities6,603.5 6,829.1 
Held for sale liabilities— 47.2 
Total current liabilities6,603.5 6,876.3 
Long-term debt4,662.8 4,634.2 
Deferred and other tax liabilities238.3 245.2 
Contract liabilities1,639.9 1,583.2 
Accrued and other liabilities257.5 250.9 
Total non-current liabilities6,798.5 6,713.5 
Total liabilities13,402.0 13,589.8 
Total shareholders’ equity13,865.4 13,628.9 
Total liabilities and shareholders’ equity27,267.4 27,218.7 



ASML - Summary US GAAP Consolidated Statements of Cash Flows
Three months ended,
Mar 29,Apr 4,
 (unaudited, in millions €)20202021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income390.6 1,331.4 
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization 118.3 117.9 
Impairment2.7 — 
Loss on disposal of property, plant and equipment1.0 6.2 
Share-based compensation expense14.9 21.0 
Allowance for obsolete inventory39.3 34.4 
Deferred income taxes(24.6)(35.8)
Equity method investments(32.3)(21.5)
Changes in assets and liabilities(1,115.7)(2,395.3)
Net cash provided by (used in) operating activities(605.8)(941.7)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment(231.5)(189.4)
Purchase of intangible assets(10.8)(7.9)
Purchase of short-term investments(310.5)(608.5)
Maturity of short-term investments108.2 499.1 
Loans issued and other investing0.3 — 
Net cash provided by (used in) investing activities(444.3)(306.7)
CASH FLOWS FROM FINANCING ACTIVITIES
Purchase of shares(507.5)(1,567.6)
Net proceeds from issuance of shares8.6 11.0 
Net proceeds from issuance of notes, net of issuance costs739.8 — 
Repayment of debt and finance lease obligations(0.9)(3.6)
Net cash provided by (used in) financing activities240.0 (1,560.2)
Net cash flows(810.1)(2,808.6)
Effect of changes in exchange rates on cash1.5 3.0 
Net increase (decrease) in cash and cash equivalents(808.6)(2,805.6)
Cash and cash equivalents at beginning of the period3,532.3 6,049.4 
Cash and cash equivalents at end of the period2,723.7 3,243.8 



ASML - Quarterly Summary US GAAP Consolidated Statements of Operations
Three months ended,
Mar 29,Jun 28,Sep 27,Dec 31,Apr 4,
 (unaudited, in millions €, except per share data)20202020202020202021
Net system sales1,584.0 2,438.6 3,095.6 3,198.3 3,128.8 
Net service and field option sales856.6 887.1 862.4 1,055.8 1,235.1 
Total net sales2,440.6 3,325.7 3,958.0 4,254.1 4,363.9 
Total cost of sales(1,339.2)(1,722.5)(2,076.6)(2,043.0)(2,011.5)
Gross profit1,101.4 1,603.2 1,881.4 2,211.1 2,352.4 
Research and development costs(544.0)(566.9)(534.0)(555.9)(623.4)
Selling, general and administrative costs(130.7)(131.2)(131.5)(151.5)(168.4)
Income from operations426.7 905.1 1,215.9 1,503.7 1,560.6 
Interest and other, net(11.4)(7.1)(8.4)(8.0)(12.1)
Income before income taxes415.3 898.0 1,207.5 1,495.7 1,548.5 
Benefit from (provision for) income taxes(48.5)(166.4)(166.5)(170.2)(230.3)
Income after income taxes366.8 731.6 1,041.0 1,325.5 1,318.2 
Profit related to equity method investments23.8 19.4 20.5 25.0 13.2 
Net income390.6 751.0 1,061.5 1,350.5 1,331.4 
Basic net income per ordinary share0.93 1.79 2.54 3.23 3.21 
Diluted net income per ordinary share

0.93 1.79 2.53 3.23 3.20 
Weighted average number of ordinary shares used in computing per share amounts (in millions):
Basic419.0 418.4 418.4 417.5 415.3 
Diluted

419.7 419.0 419.2 418.4 415.8 


ASML - Quarterly Summary Ratios and other data
Mar 29,Jun 28,Sep 27,Dec 31,Apr 4,
(unaudited, in millions €, except otherwise indicated)20202020202020202021
Gross profit as a percentage of net sales45.1 %48.2 %47.5 %52.0 %53.9 %
Income from operations as a percentage of net sales 17.5 %27.2 %30.7 %35.3 %35.8 %
Net income as a percentage of net sales16.0 %22.6 %26.8 %31.7 %30.5 %
Income taxes as a percentage of income before income taxes11.7 %18.5 %13.8 %11.4 %14.9 %
Shareholders’ equity as a percentage of total assets 53.8 %52.2 %54.0 %50.8 %50.1 %
Sales of lithography systems (in units) 1
57 61 60 80 76 
Value of booked systems (EUR millions) 2
3,085 

1,101 

2,868 

4,238 

4,740 
Net bookings lithography systems (in units) 1, 2
73 

34 

73 

123 

120 
Number of payroll employees in FTEs23,860 24,330 24,749 26,614 27,248 
Number of temporary employees in FTEs1,467 1,482 1,451 1,459 1,561 








1     Lithography systems do not include metrology and inspection systems.
2 Our systems net bookings include all system sales orders for which written authorizations have been accepted (for EUV excluding the High-NA systems).


ASML - Quarterly Summary US GAAP Consolidated Balance Sheets
Mar 29,Jun 28,Sep 27,Dec 31,Apr 4,
(unaudited, in millions €)20202020202020202021
ASSETS
Cash and cash equivalents2,723.7 3,499.1 3,531.5 6,049.4 3,243.8 
Short-term investments1,388.1 941.2 876.3 1,302.2 1,411.6 
Accounts receivable, net1,767.4 1,770.0 2,458.8 1,310.3 2,239.2 
Finance receivables, net748.7 1,071.5 1,855.4 1,710.5 2,218.6 
Current tax assets529.0 360.8 265.6 67.3 809.7 
Contract assets292.1 260.9 176.8 119.2 107.4 
Inventories, net4,345.3 4,685.6 4,613.7 4,569.4 4,748.1 
Other assets905.8 903.5 772.7 801.7 915.7 
Held for sale assets— — — — 165.5 
Total current assets12,700.1 13,492.6 14,550.8 15,930.0 15,859.6 
Finance receivables, net340.8 444.0 349.6 400.5 66.6 
Deferred tax assets

482.3 485.3 610.7 671.5 700.8 
Other assets902.3 929.7 961.5 951.4 1,313.4 
Equity method investments865.1 891.6 918.0 820.7 842.5 
Goodwill4,541.1 4,541.1 4,541.1 4,629.1 4,555.5 
Other intangible assets, net1,082.5 1,058.3 1,035.4 1,049.0 1,014.2 
Property, plant and equipment, net 2,046.9 2,109.6 2,198.3 2,470.3 2,521.6 
Right-of-use assets - Operating197.1 193.0 180.1 180.1 179.7 
Right-of-use assets - Finance119.4 160.9 117.9 164.8 164.8 
Total non-current assets10,577.5 10,813.5 10,912.6 11,337.4 11,359.1 
Total assets23,277.6 24,306.1 25,463.4 27,267.4 27,218.7 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities4,677.4 4,631.3 4,990.9 6,603.5 6,829.1 
Held for sale liabilities— — — — 47.2 
Total current liabilities

4,677.4 4,631.3 4,990.9 6,603.5 6,876.3 
Long-term debt3,868.2 4,625.0 4,626.7 4,662.8 4,634.2 
Deferred and other tax liabilities

262.7 191.3 209.1 238.3 245.2 
Contract liabilities1,702.6 1,918.1 1,652.8 1,639.9 1,583.2 
Accrued and other liabilities241.5 240.6 241.4 257.5 250.9 
Total non-current liabilities6,075.0 6,975.0 6,730.0 6,798.5 6,713.5 
Total liabilities10,752.4 11,606.3 11,720.9 13,402.0 13,589.8 
Total shareholders’ equity12,525.2 12,699.8 13,742.5 13,865.4 13,628.9 
Total liabilities and shareholders’ equity23,277.6 24,306.1 25,463.4 27,267.4 27,218.7 



ASML - Quarterly Summary US GAAP Consolidated Statements of Cash Flows
Three months ended,
Mar 29,Jun 28,Sep 27,Dec 31,Apr 4,
 (unaudited, in millions €)20202020202020202021
CASH FLOWS FROM OPERATING ACTIVITIES
Net income390.6 751.0 1,061.5 1,350.6 1,331.4 
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization118.3 125.1 122.0 125.4 117.9 
Impairment2.7 — — — — 
Loss on disposal of property, plant and equipment1.0 0.2 0.8 0.8 6.2 
Share-based compensation expense14.9 10.3 22.5 6.2 21.0 
Allowance for obsolete inventory39.3 39.2 36.3 77.6 34.4 
Deferred income taxes(24.6)(15.4)(110.6)(60.7)(35.8)
Equity method investments(32.3)(26.4)(26.1)95.8 (21.5)
Changes in assets and liabilities(1,115.7)(512.1)(915.3)3,074.7 (2,395.3)
Net cash provided by (used in) operating activities(605.8)371.9 191.1 4,670.4 (941.7)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment(231.5)(225.1)(212.5)(292.9)(189.4)
Purchase of intangible assets(10.8)(6.7)(9.1)(12.2)(7.9)
Purchase of short-term investments(310.5)(0.5)(343.7)(820.8)(608.5)
Maturity of short-term investments108.2 447.4 408.7 394.8 499.1 
Loans issued and other investing0.3 (0.3)(10.0)(2.2)— 
Acquisition of subsidiaries (net of cash acquired)— — — (222.8)— 
Net cash provided by (used in) investing activities(444.3)214.8 (166.6)(956.1)(306.7)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividend paid— (564.8)— (501.6)— 
Purchase of shares(507.5)— — (700.0)(1,567.6)
Net proceeds from issuance of shares8.6 11.0 10.4 7.9 11.0 
Net proceeds from issuance of notes, net of issuance costs739.8 746.5 — — — 
Repayment of debt and finance lease obligations(0.9)(0.8)(0.9)(0.7)(3.6)
Net cash provided by (used in) financing activities240.0 191.9 9.5 (1,194.4)(1,560.2)
Net cash flows(810.1)778.6 34.0 2,519.9 (2,808.6)
Effect of changes in exchange rates on cash1.5 (3.2)(1.6)(2.0)3.0 
Net increase (decrease) in cash and cash equivalents(808.6)775.4 32.4 2,517.9 (2,805.6)
Cash and cash equivalents at beginning of the period3,532.3 2,723.7 3,499.1 3,531.5 6,049.4 
Cash and cash equivalents at end of the period2,723.7 3,499.1 3,531.5 6,049.4 3,243.8 


Notes to the Summary US GAAP Consolidated Financial Statements

Basis of preparation
The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the accounting principles generally accepted in the United States of America ("US GAAP").
For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included within our 2020 Annual Report based on US GAAP, which is available on www.asml.com.



Forward Looking Statements
This document contains statements that are forward-looking, including statements with respect to expected trends, including trends in end markets and technology industry and business environment trends, outlook and expected financial results for Q2 2021, including expected revenues, gross margin, R&D costs, SG&A costs and estimated annualized effective tax rate for 2021, expected growth in net sales in 2021, expectations on gross margin, R&D and SG&A for full year 2021, system bookings, expected increases in Logic and Memory demand and revenue, expected trends in IBM revenue, long term growth opportunity, revenue opportunity through 2025, future growth outlook towards 2025 and long term demand drivers, expected benefits and performance of new systems and applications, expanding end market applications driving semiconductor demand, the expectation that EUV will continue to enable Moore's law and drive long term value for ASML, expected trends in demand, expected increase in output capability, product roadmap, expected EUV tool productivity and expectations on shipments in 2022, statements with respect to plans regarding dividends, including the intention to continue to return significant amounts of cash to shareholders through a combination of share buybacks and growing annualized dividends, the amount of the final dividend for 2020 and statements with respect to the 2020-2022 share buyback program including the amount of shares intended to be repurchased under the program and that expected cash generation enables opportunity for continued significant buybacks and that ASML expects early completion of the buyback program. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions; product demand and semiconductor equipment industry capacity; worldwide demand and manufacturing capacity utilization for semiconductors; the impact of general economic conditions on consumer confidence and demand for our customers’ products; performance of our systems, the duration and continued or increased severity of the COVID-19 outbreak and measures taken to contain it and other risks related to the impact of COVID-19 on the global economy and financial markets, as well as on ASML and its customers and suppliers, including their operations, and other risks relating to COVID-19 and other factors that may impact ASML’s sales and gross margin, including customer demand (including demand in Logic and Memory and for our IBM services) and ASML’s ability to obtain supplies for its products, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products, production capacity and our ability to increase capacity, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push out, production capacity for our systems including delays in system production; our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation; availability of raw materials, critical manufacturing equipment and qualified employees; trade environment; import/export and national security regulations and orders and their impact on us, changes in exchange and tax rates; available liquidity and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, results of the share repurchase programs and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.